Conditionally Reprogrammed Cells as a New Tool for Biobanking Conditionally Reprogrammed Cells as a New Tool for Biobanking ASU will provide sequencing service and analysis for the targeted tumor sequencing using Mi-Seq and the Exome Sequencing using Hi-Seq. We will also provide bioinformatics analysis of the exome sequencing.
|Effective start/end date||8/31/15 → 8/31/16|
- HHS-NIH: National Cancer Institute (NCI): $59,057.00
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.